New clinical trial shows increased asthma control with FeNO-guided anti … – News-Medical.net

New clinical trial shows increased asthma control with FeNO-guided anti
News-Medical.net
A total of 187 non-smoking asthma patients (18-64 years) with perennial allergy and on regular inhaled corticosteroid (ICS) treatment were recruited at 17 primary health care centres in Sweden, randomly assigned to two groups and followed for one year.
AEROCRINE AB : Aerocrine: First Primary Care Trial Supports FeNO-Guided 4-traders (press release)

all 3 news articles »

View full post on asthma – Google News

AEROCRINE AB : Aerocrine: First Primary Care Trial Supports FeNO-Guided … – 4-traders (press release)

AEROCRINE AB : Aerocrine: First Primary Care Trial Supports FeNO-Guided
4-traders (press release)
Aerocrine AB (STO:AERO-B) – A new randomised clinical trial shows lower incidence of asthma exacerbations and increased asthma control with Fractional exhaled Nitric Oxide (FeNO)-guided anti-inflammatory treatment. The study has been published on 

and more »

View full post on asthma – Google News